secwatch.observer — SEC 8-K summary
======================================

Issuer:     KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU)
CIK:        0000055529
Form:       8-K
Filed at:   2023-06-28T23:59:59+00:00
Accession:  0000055529-23-000009
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Kewaunee Scientific posts Q4 profit of $0.34/share; FY revenue up 30% to $219.5M
--------------------------------------------------------------------------------

- Q4 net earnings $1,005,000 ($0.34 diluted EPS) vs net loss of $362,000 ($0.13 loss) in prior year.
- Q4 sales $53,986,000, up 8.6% YoY; International segment sales surged 57.3% to $18,863,000.
- Full fiscal year 2023 net earnings $738,000 ($0.25 EPS) vs net loss $6,126,000 ($2.20 loss); sales up 30% to $219,494,000.
- EBITDA for FY2023 improved to $7,517,000 from $394,000; domestic segment returned to profit.
- Backlog at April 30, 2023 was $147.9 million, down from $173.9 million a year ago; cash increased to $13.8 million from $6.9 million.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/55529/000005552923000009/0000055529-23-000009-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/55529/000005552923000009/kequ-20230628.htm
  HTML page:      https://secwatch.observer/filing/0000055529-23-000009

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer